May 4, 2020 / 10:03 PM / 23 days ago

BRIEF-Corcept Therapeutics Says Q1 Non-GAAP EPS Of $0.34

May 4 (Reuters) - Corcept Therapeutics Inc:

* CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* REPORTS Q1 REVENUE OF $93.2 MILLION

* Q1 NON-GAAP EARNINGS PER SHARE $0.34

* SEES FY 2020 REVENUE $355 MILLION TO $375 MILLION

* Q1 REVENUE $93.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $87 MILLION

* Q1 EARNINGS PER SHARE ESTIMATE $0.22 — REFINITIV IBES DATA

* COVID-19 PANDEMIC’S FUTURE IMPACT ON CORCEPT IS DIFFICULT TO ESTIMATE

* FY2020 REVENUE VIEW $363.8 MILLION — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below